Alpha Cognition Inc
ACOG
Peringkat dalam Saham
#20080
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Harga Saham
$8.66
Kapitalisasi Pasar
$134.50M
Perubahan (1 hari)
1.88%
Perubahan (1 tahun)
72.17%
Negara
US
Perdagangan Alpha Cognition Inc (ACOG)
Kategori
Healthcare
Jumlah saham beredar untuk Alpha Cognition Inc (ACOG)
Jumlah saham beredar per June 2026: 21.77M
Menurut laporan keuangan terbaru dan harga saham Alpha Cognition Inc, jumlah saham beredar saat ini adalah 21.77M. Pada akhir December 2022, perusahaan memiliki 67.97M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Alpha Cognition Inc (ACOG) dari 2018 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 21.77M | -76.92% |
| 2023 | 94.36M | 38.81% |
| 2022 | 67.97M | 27.45% |
| 2021 | 53.33M | 786.67% |
| 2020 | 6.02M | -80.88% |
| 2019 | 31.46M | 2,539.28% |
| 2018 | 1.19M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | 1,066.06% |
US
|
|
| 396.00M | 1,718.67% |
US
|
|
| 478.91M | 2,099.46% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 185.59% |
NL
|
